Ista Pharmaceuticals

Ista Pharmaceuticals is a pharmaceutical company that develops proprietary therapeutic products focused on the ophthalmic market. In 2008, Ista was in a dire financial position due to the upcoming maturity of convertible debt in early 2009. The weak equity markets had pushed its market cap from $175 million at the beginning of the year to just under $50 million.